Tech Company Financing Transactions

Achillion Pharmaceuticals Funding Round

Achillion Pharmaceuticals secured a $13.8 million funding round on 6/30/2006. Investors included Advent International, Bear Stearns Health Innoventures and Connecticut Innovations.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

1777 Sentry Pkwy. West VEVA Building #14 200
Blue Bell, PA 19422
USA

Phone

215-709-3040

Website

www.achillion.com

Email Address

[email protected]

Overview

Achillion is a science-driven, patient-focused company with the goal of providing better treatments for people with serious diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Joseph Truitt

        

Chief Financial Officer

Brian Di Donato

        

Chief Medical Officer

Steven Zelenkofske

        

Chief Operating Officer

Paul Firuta

        

Vice President

Susanne Heinzinger

        

VP - Bus. Development

Michael Geffner

        

VP - Bus. Development

Anthony Gibney

        

VP - General Counsel

Martha Manning

        

VP - Human Resources

Ky Nam-Wortman

        

VP - R & D

Mingjun Huang

        

VP - Regulatory Affairs

Kevin Malobisky

        

Browse more venture capital transactions:

Prev: 6/30/2006: Partsearch Technologies venture capital transaction
Next: 6/30/2006: USGI Medical venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary